Candriam SCA’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-383,000	Closed	-$3.33M	–	696
2024 Q2	$3.33M	Hold	383,000	–	–	0.02%	401
2024 Q1	$7.92M	Buy	383,000 +243,000	+174%	+$5.02M	0.05%	284
2023 Q4	$3.24M	Buy	+140,000	New	+$3.24M	0.02%	402